PRESS RELEASE published on 09/07/2023 at 10:30, 1 year 2 months ago Theralase(R) Closes Private Placement Equity Financing
PRESS RELEASE published on 08/29/2023 at 22:30, 1 year 2 months ago Theralase Release’s 2Q2023 Interim Financial Statements
PRESS RELEASE published on 06/30/2023 at 22:35, 1 year 4 months ago Theralase(R) Closes Non-Brokered Private Placement Equity Financing
PRESS RELEASE published on 06/06/2023 at 13:00, 1 year 5 months ago Theralase(R) Announces Appointment of New Independent Director
PRESS RELEASE published on 05/31/2023 at 03:30, 1 year 5 months ago Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements
PRESS RELEASE published on 05/31/2023 at 01:35, 1 year 5 months ago Theralase(R) Releases 1Q2023 Interim Financial Statements
PRESS RELEASE published on 05/25/2023 at 00:45, 1 year 5 months ago Theralase(R) Appoints Roger DuMoulin-White as President and Chief Executive Officer
PRESS RELEASE published on 05/10/2023 at 13:00, 1 year 6 months ago Theralase Provides Update on Phase II Bladder Cancer Study
Published on 11/22/2024 at 23:55, 9 hours 28 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 53 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 18 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 53 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 15 hours 8 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 30 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 28 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 23 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 14 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
